Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3797-3799

  Geier, Debra ^a   Hebert, Brian ^a   Potti, Anil ^a  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Association; Carcinoma; Hemochromatosis; Non hepatocellular

Indexed keywords

HLA ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHILD; COLORECTAL CANCER; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEREDITY; HODGKIN DISEASE; HUMAN; IRON OVERLOAD; IRON STORAGE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CARCINOMA;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; COHORT STUDIES; FEMALE; HEMOCHROMATOSIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0036875901     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Powel LW and Isselbacher KJ: Harrison's Principles of Internal Medicine. New York, McGraw Hill 342: 2149, 1998.
2. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S and Fraumeni JF: Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark. Int J Cancer 60: 160-62, 1995.
3. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ and Strohmeyer G: Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256-71, 1985.
4. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D and Strohmeyer G: Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110: 1107-19, 1996.
5. Nelson RL, Davis FG, Persky V and Becker E: Risk of neoplastic and other diseases among people with heterozygosity for hereditary Hemochromatosis. Cancer 76: 875-79, 1995.
6. Stevens RG, Graubard BI, Micozzi MS, NeriishiK and Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56: 364-69, 1994.
7. Knekt P, Reunanen A, Takkenen H, Aromaa A, Heliovaara M and Hakulinen T: Body iron stores and risk of cancer. Int J Cancer 56: 379-82, 1994.
8. Ammann RW, Muller E, Bansky J, Schuler G and Hacki WH: High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J Gastroent 15: 733-36, 1980.
9. Weinberg, ED: The Role of iron in cancer. Eur J Cancer Prev 5: 19-36, 1996.
10. Stevens RG, Jones Y, Micozzi MS and Taylor PR: Body iron stores and the risk of cancer. N Engl J Med 319: 1047-52, 1988.
11. Beckman LE, Van Landeghen GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, Lenner P, Athlin L, Stenling R and Breckman L: Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 20: 1231-33, 1999.
12. Bain C, Bradbear R, Siskind V, Schofield F, Basset M, Halliday J and Powell L: Cohort study of the risk of malignancy in haemochromatosis and other nonalcoholic liver diseases. Hepatology 4: 1020, 1984.
13. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L and Edwards BK: SEER Cancer Statistics Review, 1973-1978, National Cancer Institute. Bethesda, MD, 2001.
14. McCord JM: Iron and Oxidative Balance. Iron and Human Disease. Boca Raton, CRC Press 509-18, 1992.
15. De Sousa M: The Immunology of Iron Overload. Iron in Immunity, Cancer, and Inflammation. Chichester, J Wiley 247-58, 1989.
16. Djeha A and Brock JH: Effect of transferrin, lactoferrin, and chelated iron on human T-lymphocytes. Br J Haemotol 80: 235-41, 1992.
17. Cazzola M, Bergamaschi G, Dezza L and Arosio P: Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 75: 1903-19, 1990.
18. Boldt DH. New Perspectives on Iron: An introduction. Am J Med Sci 318: 207-12, 1999.
19. Francanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A and Fargion S: Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33: 647-51, 2001.
20. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Akhmedkhanov A and Riboli E: Iron intake, body iron stores and colorectal cancer risk in women: A Nested Case-Control Study. Int J Cancer 80: 693-98, 1999.
21. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall W and Bowen P: Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 86: 455-60, 1994.
22. Kato I: Iron Nutriture and Risk of Cancer. Nutr Rev 47: 176-78, 1989.